Evaluation of antiviral drugs against newly emerged SARS-CoV-2 Omicron subvariants.
Journal Information
Full Title: Antiviral Res
Abbreviation: Antiviral Res
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Anti-Infective Agents
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"data availability data will be made available on request. appendix a supplementary data to this article can be found online at https://doi"
"Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."
"Funding This work was supported by the 10.13039/501100003653Korea National Institute of Health [grant numbers 2021-NI-026-02, 6634-325-210]."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025